Sanofi Pasteur Biologics, LLC

Sanofi Pasteur Inc.

Ares Trading S.a.

Peptimmune, Inc.

Jianxin Zhang

Harold Kleanthous

Pierre Garrone

Stephen F Anderson

Nicola Beltraminelli

Natalie Anosova

Majid Mehtali

Sam Baldwin

Dustan Bonnin

Eric Zanelli

James Rasmussen

Bei Yu

Keith Johnson

Monoclonal antibodies, or antigen-binding fragments thereof, that bind to() toxin A or toxin B and methods of using the same to detect or treatinfections and/or-associated disease.

Antibodies against clostridium difficile toxins and methods of using the same

Antibodies againsttoxins and methods of using the same

Monoclonal antibodies or antigen-binding fragments thereof, that bind to() toxin A or toxin B and methods of using the same to detect or treatinfections and/or-associated disease.is a gram positive, anaerobic bacterium that causes gastrointestinal disease in humans. The bacteria are transmitted through feces and spread to food and other surfaces when people who are infected do not thoroughly wash their hands.

[object Object]

The invention relates to novel methods and kits for treating or preventing disease through the administration of random copolymers comprising amino acids tyrosine (Y), phenylalanine (F), alanine (A), and lysine (K). The invention also relates to the treatment of autoimmune diseases, such as multiple sclerosis, and to the administration of random copolymers in treatment regimen comprising formulations that are administered at intervals greater than 24 hours, or to sustained release formulations which administer the copolymer over a period greater than 24 hours. The invention further relates to methods for conducting a pharmaceutical business comprising manufacturing, licensing, or distributing kits containing or relating to the formulations or dosing regimens of random copolymer described herein.

Methods of treating disease with random copolymers

Growing community of inventors

Acton, MA, United States of America

Jianxin Zhang